21.57+0.83 (+4.00%)
At close: 4:00PM EST
21.57 0.00 (0.00%)
After hours: 4:26PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 20.74 |
| Open | 20.99 |
| Bid | 21.50 x 900 |
| Ask | 21.60 x 900 |
| Day's Range | 20.93 - 21.67 |
| 52 Week Range | 12.63 - 31.77 |
| Volume | 129,940 |
| Avg. Volume | 277,703 |
| Market Cap | 838.154M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.37 |
| Earnings Date | Feb 11, 2021 - Feb 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 09, 2015 |
| 1y Target Est | 27.63 |
- PR Newswire
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's ongoing PROACT Xa trial on December 7, 2020 at 4:00 p.m. EST.
- Zacks
CryoLife (CRY) Q3 Earnings and Revenues Surpass Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 1400.00% and 12.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
CryoLife Reports Third Quarter 2020 Financial Results
Third Quarter and Recent Business Highlights:
© 2020 Verizon Media. All rights reserved.
